New way to improve the efficacy of innovative RNA therapies
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Jul-2025 01:10 ET (2-Jul-2025 05:10 GMT/UTC)
A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of RNA-based drugs can significantly enhance their effectiveness. These promising therapeutics are currently used to treat rare genetic diseases.
Northwestern Medicine scientists have developed an AI tool called iSeg that not only matches doctors in accurately outlining lung tumors on CT scans but can also identify areas that some doctors may miss, reports a large new study.
Pitt School of Medicine and La Jolla Institute for Immunology collaboration reveals an opportunity for developing a therapy against the leading infectious cause of birth defects in the United States.
Researchers at the Gray Faculty of Medical and Health Sciences at Tel Aviv University have developed a model that accurately replicates an extremely rare and sometimes fatal genetic disorder caused by a mutation in the GRIN2D gene. This mouse model allows the research team to study the disease’s characteristics and test a variety of drugs and genetic therapies, offering hope to affected children and their families.
A newly published ESC Clinical Consensus Statement describes the pivotal role of vaccination in the prevention of cardiovascular events.
Infections such as pneumonia, influenza and SARS-CoV-2, among others, exacerbate heart failure and increase the risk of major cardiovascular events. In addition to preventing infections, vaccination can reduce cardiovascular complications, particularly in at-risk patients with existing cardiovascular disease.
The new document concludes that vaccination should be considered as a foundational pillar for cardiovascular prevention alongside other established measures.
A new national survey of 1,000 American adults commissioned by The Ohio State University Wexner Medical Center and College of Medicine finds that stress and anxiety contribute most to a short attention span (43%), followed by lack of sleep (39%) and digital devices (35%).
As public health insurance in the United States faces potential cuts, a Rutgers University review of medical records finds that Medicaid and Medicare patients with opioid addiction tend to receive behavioral health care services less often than those with other types of funding.